HETEROGENEOUS IGG SUBCLASS DISTRIBUTION OF ISLET-CELL ANTIBODIES

被引:17
|
作者
DOZIO, N
BELLONI, C
GIRARDI, AM
GENOVESE, S
SODOYEZ, JC
BOTTAZZO, GF
POZZA, G
BOSI, E
机构
[1] STATE UNIV LIEGE,DEPT EXPTL NUCL MED,B-4000 LIEGE,BELGIUM
[2] UNIV LONDON LONDON HOSP,COLL MED,DEPT IMMUNOL,LONDON E1 2AD,ENGLAND
关键词
D O I
10.1006/jaut.1994.1004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Islet cell antibodies (ICA)-IgG are the serological marker of type 1 diabetes, an organ-specific autoimmune disease. A proportion of patients also have thyro-gastric autoimmunity, implying a broader humoral autoreactivity in these cases. In order to determine whether this is also reflected within islet cell antibodies (ICA) we examined the ICA-IgG subclass distribution in type 1 diabetic patients with or without associated thyro-gastric autoantibodies. ICA-IgG subclasses were detected by two-step indirect immunofluorescence, using monoclonal antibodies against the four IgG subclasses, in sera from 51 patients with type 1 diabetes and detectable ICA; 31 had no other antibodies (group 1) and 20 had at least one associated thyroid and/or gastric autoantibody (group 2). Our results show that ICA are polyclonal and invariably IgG1. In 48% of patients with type 1 diabetes without associated thyro-gastric autoantibodies, ICA were restricted to IgG1 only. Conversely, only 10% of those with thyro-gastric antibodies had ICA-IgG1 only (P < 0.02), and a larger ICA-IgG subclass recruitment was observed in these patients (P = 0.002). These findings provide evidence of heterogeneity within ICA at the IgG subclass level, with a broader clonal recruitment within this specificity in individuals displaying features of multiple organ autoimmunity. These results support the hypothesis of heterogeneity within the pathogenetic process leading to type 1 diabetes. © 1994 Academic Press, Inc.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 50 条
  • [21] COMPLICATIONS OF MUMPS INFECTION, ISLET-CELL ANTIBODIES, AND HLA
    MUELLERECKHARDT, G
    STIEF, T
    OTTEN, A
    HELMKE, K
    WILLEMS, WR
    MUELLERECKHARDT, C
    IMMUNOBIOLOGY, 1984, 167 (04) : 338 - 344
  • [22] GLYCOLIPIDS AS THE MAJOR AUTOANTIGENS OF CYTOPLASMATIC ISLET-CELL ANTIBODIES
    CABRERARODE, E
    DIAZHORTA, O
    FERNANDEZ, LE
    CARR, A
    MARQUINA, G
    VALIENTE, O
    GONZALEZSUAREZ, RM
    URIARTE, A
    AUTOIMMUNITY, 1995, 20 (03) : 145 - 151
  • [23] SERIAL CHANGES IN THE PREVALENCE OF ISLET-CELL ANTIBODIES AND ISLET-CELL ANTIBODY TITER IN CHILDREN WITH IDDM OF ABRUPT OR SLOW ONSET
    URAKAMI, T
    MIYAMOTO, Y
    MATSUNAGA, H
    OWADA, M
    KITAGAWA, T
    DIABETES CARE, 1995, 18 (08) : 1095 - 1099
  • [24] ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
    Bottazzo, Gian Franco
    Florin-Christensen, Alejo
    Doniach, Deborah
    JOURNAL OF IMMUNOLOGY, 2017, 199 (09): : 3014 - 3018
  • [25] RHESUS-MONKEY PANCREAS FOR MEASURING ISLET-CELL ANTIBODIES
    CROSSLEY, JR
    LENDRUM, BD
    ELLIOTT, RB
    LANCET, 1977, 1 (8024): : 1267 - 1267
  • [26] ISLET-CELL TUMOURS
    不详
    BRITISH MEDICAL JOURNAL, 1946, 1 (4443): : 321 - 321
  • [27] COMPARISON OF VARIOUS ASSAYS ON THE DETERMINATION OF CYTOPLASMIC ISLET-CELL ANTIBODIES
    GLEICHMANN, H
    BONIFACIO, E
    BOTTAZZO, GF
    DIABETES, 1986, 35 : A183 - A183
  • [28] COMPLEMENT-FIXING ISLET-CELL ANTIBODIES - A SEPARATE SPECIES
    RILEY, WJ
    NEUFELD, M
    MACLAREN, NK
    LANCET, 1980, 1 (8178): : 1133 - 1133
  • [29] CONTRIBUTION OF GLUTAMATE-DECARBOXYLASE ANTIBODIES TO THE REACTIVITY OF ISLET-CELL CYTOPLASMIC ANTIBODIES
    MARSHALL, MO
    HOYER, PE
    PETERSEN, JS
    HEJNAES, KR
    GENOVESE, S
    DYRBERG, T
    BOTTAZZO, GF
    JOURNAL OF AUTOIMMUNITY, 1994, 7 (04) : 497 - 508
  • [30] IGG SUBCLASS DISTRIBUTION OF ANTIBODIES TO BACTERIAL AND VIRAL-ANTIGENS
    FERRANTE, A
    BEARD, LJ
    FELDMAN, RG
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (08) : S16 - S24